Because MSI2 physically interacts with CAV1 and reduces CAV1 protein expression in NF1-MPNST cell lines, we then investigated whether CAV1 degradation could be modulated by MSI2. The gene discussed is MSI2; the disease is malignant peripheral nerve sheath tumor.